サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1629326

神経血管塞栓装置の世界市場：製品別・最終用途別・国別・地域別 - 産業分析、市場規模・シェア、将来予測 (2025年～2032年)

Neurovascular Embolization Devices Market, By Product, By End Use, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032

出版日
ページ情報
英文 301 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
神経血管塞栓装置の世界市場：製品別・最終用途別・国別・地域別 - 産業分析、市場規模・シェア、将来予測 (2025年～2032年)
出版日: 2024年12月04日
発行: AnalystView Market Insights
ページ情報: 英文 301 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

レポートハイライト

神経血管塞栓装置の市場規模は2024年に15億6,160万米ドルとなり、2025年から2032年にかけてCAGR 8.90%で拡大

神経血管塞栓装置の市場力学

脳卒中および動脈瘤症例の増加

予測期間を通じて、脳卒中や動脈瘤の症例数の増加が世界の神経血管塞栓装置市場の拡大を促進すると予測されています。例えば、世界脳卒中機構は、脳卒中の流行はすでに到達していると主張しています。1,220万人以上が今年初めて脳卒中を発症し、650万人がその結果死亡すると予想されており、25歳以上の成人の4人に1人が人生のどこかで脳卒中を発症することになります。世界全体では、1億1,000万人以上が人生のある時期に脳卒中を経験しています。脳卒中の有病率は年齢とともに急激に上昇するにもかかわらず、脳卒中の60%以上が70歳未満で発症し、16%以上が50歳未満で発症しています。さらに、NHSイングランドは、イングランドでは年間12,500人に1人が脳動脈瘤の破裂に苦しんでいると推定しています。さらに、脳動脈瘤財団は、毎年600万人以上のアメリカ人が脳動脈瘤に罹患し、英国では3.0%以上の人が脳動脈瘤に罹患していると推定しています。さらにNIHの報告によると、脳動脈瘤の有病率は全世界で約3.2%であり、標準年齢は50歳、男女比は全体で1：1です。50歳を過ぎると、この比率は大きく変化し、女性優位が強まり、2：1になります。これは、循環エストロゲンレベルの低下により、血管組織のコラーゲン範囲が減少するためと考えられています。

神経血管塞栓装置市場：主な考察

当社のリサーチアナリストが共有した分析によると、世界市場は予測期間 (2025-2032年) に約8.90%のCAGRで毎年成長すると推定されます。

製品別に見ると、塞栓コイルが2024年に最大市場シェアを示すと予測されました。

最終用途別に見ると、2024年には病院が主要カテゴリーでした。

地域別では、北米が2024年の売上高でトップでした。

神経血管塞栓装置市場：セグメンテーション分析

神経血管塞栓装置の世界市場は、製品、最終用途別、地域別に区分されます。

製品別では、市場は液体塞栓剤、塞栓コイル、動脈瘤クリップ、流路転換デバイス、その他に分別されます。2024年、市場は塞栓コイルカテゴリーが支配的でした。塞栓コイルと呼ばれる複雑なプラチナ製器具は、血栓を形成させるために動脈に挿入されます。これらのコイルは動脈瘤やその他の血管異常をうまく遮断し、破裂やそれに伴う出血の可能性を低下させます。さまざまな解剖学的合併症に適応できるため、非常に人気があります。生体活性のある脱着可能なコイルの開発は，継続的な研究開発の結果，この分野の有効性と安全性を向上させてきました。さらに、神経血管治療における最も重要な開発のひとつは、液体塞栓の使用です。

最終用途に基づき、市場は病院、専門クリニック、その他に分けられます。2024年には、病院カテゴリーが圧倒的な市場シェアを占めています。病院は、洗練された技術、大規模なインフラ、高度な資格を持つ医療従事者を擁するため、神経血管塞栓術のような最先端の治療を行う主要な場所です。最新の画像診断機器やインターベンショナル・スイートを備えたこれらの施設には、正確な診断とオーダーメイドの治療を可能にする神経インターベンション専用ユニットが設置されていることが多いです。病院では、有能な神経外科医、インターベンショナル・ラジオロジスト、神経科医がいるため、動脈瘤や動静脈奇形などの疾患を持つ患者に対して、集学的な治療が保証されます。

神経血管塞栓装置市場：地域別分析

2024年には、北米が神経血管塞栓装置の世界市場で支配的な地位を占めています。神経血管塞栓装置の市場は、北米、特に米国とカナダで大きいです。これらの国々は神経血管疾患の罹患率が高く、医療システムが高度化し、医療費が増大しています。この地域のマーケットプレースの成長は、政府のイニシアチブの高まりとメーカーの研究開発 (R&D) 支出によって大きな影響を受けています。さらに、業界大手による製品ラインナップの多様化を目的とした新製品のイントロダクションも、この分野の成長に寄与しています。例えば、インド・メドトロニック社の第4世代流路偏向器「パイプライン・バンテージ・ウィズ・シールド・テクノロジー」はCEマークを取得しており、脳動脈瘤の血管内治療のために2022年6月に誕生しました。

しかし、予測期間を通じて、アジア太平洋地域のCAGRが最も速いと予想されています。神経学的問題の有病率の増加、技術的ブレークスルー、対象疾患の負担増などがその原因です。主要企業の存在と医療費の増加は、この地域の拡大をさらに後押しする2つの要因です。また、主要プレイヤーの地域的拡大とアジア太平洋における未開拓の大きな展望により、予測期間中に市場はさらに急成長すると予想されます。同地域の神経血管塞栓装置市場における最大の供給国は、中国、インド、日本の3ヵ国です。

神経血管塞栓装置市場：競合情勢

神経血管塞栓装置の主要企業は、Medtronic plc、Stryker Corporation、Johnson &Johnson Inc.、B. Braun Melsungen AG.、Integra LifeSciences Corporationなどです。神経血管塞栓装置の主要メーカーは、製品ラインを多様化するためにM&Aに注力しています。病院やその他の施設では、外科医や開業医に新しい神経血管塞栓装置について知らせるために、企業が会議やトレーニングセッションを開催しています。さらに、新製品のリリース、規制当局の承認、事業拡大、提携、買収、共同研究を含む成長イニシアティブは、主要企業の主な重点事項です。例えば、テルモ株式会社傘下の神経血管関連企業であるMicroVention, Inc.は、2023年7月、同社の血管内デバイスであるWEBが5年間のモニタリングデータを発表したと述べた。また、動脈瘤塞栓技術をさまざまなサイズやタイプの動脈瘤に適応できるようにするため、新たに2つのサイズ (SL 7x2とSL 6x2) を追加しました。この製品はサンディエゴで開催されるSNIS2023のブース615で展示されます。予測期間を通じて、神経血管塞栓装置の需要は、これらの開発の結果として上昇すると思われます。

最近の動向

2023年2月末梢血管塞栓術にIMPEDEとIMPEDE-FX Embolization Plugsを使用した場合の多施設登録調査であるEMBO-Post Market Surveillance Registryの一環として、ドイツで最初の患者の治療が行われたことが、末梢血管および神経血管市場向けの形状記憶ポリマーのメーカーであるShape Memory Medical Inc.から報告されました。

2022年7月：トロントで開催された第19回神経インターベンション外科学会 (SNIS) 年次総会に出席中、革新的な神経血管デバイスを設計するRapid Medical社が、大動脈閉塞に対するTIGERTRIEVER 13のFDA 510 (k) 許可を取得しました。

目次

第1章 神経血管塞栓装置市場の概要

  • 調査範囲
  • 市場推定期間

第2章 エグゼクティブサマリー

  • 市場内訳
  • 競合考察

第3章 神経血管塞栓装置の主な市場動向

  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 市場の将来動向

第4章 神経血管塞栓装置市場：産業分析

  • PEST分析
  • ポーターのファイブフォース分析
  • 市場成長の見通し：マッピング
  • 規制体制の分析

第5章 神経血管塞栓装置市場：COVID-19の影響分析

  • COVID-19以前の影響分析
  • COVID-19以後の影響分析

第6章 神経血管塞栓装置の市場情勢

  • 神経血管塞栓装置の市場シェア分析 (2024年)
  • 主要メーカー別の内訳データ
    • 既存企業の分析
    • 新興企業の分析

第7章 神経血管塞栓装置市場：製品別

  • 概要
    • セグメント別シェア分析：製品別
    • 液体塞栓剤
    • 塞栓コイル
    • 動脈瘤クリップ
    • 流れ転換装置
    • その他

第8章 神経血管塞栓装置市場：最終用途別

  • 概要
    • セグメント別シェア分析：最終用途別
    • 病院
    • 専門クリニック
    • その他

第9章 神経血管塞栓装置市場：地域別

  • イントロダクション
  • 北米
    • 概要
    • 北米の主要メーカー
    • 米国
    • カナダ
  • 欧州
    • 概要
    • 欧州の主要メーカー
    • ドイツ
    • フランス
    • イタリア
    • スペイン
    • 英国
    • ロシア
    • オランダ
    • スウェーデン
    • ポーランド
    • その他
  • アジア太平洋 (APAC)
    • 概要
    • アジア太平洋の主要メーカー
    • インド
    • 中国
    • 韓国
    • 日本
    • オーストラリア
    • タイ
    • インドネシア
    • フィリピン
    • その他
  • ラテンアメリカ
    • 概要
    • ラテンアメリカの主要メーカー
    • ブラジル
    • メキシコ
    • アルゼンチン
    • コロンビア
    • その他
  • 中東・アフリカ
    • 概要
    • 中東・アフリカの主要メーカー
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • トルコ
    • アルジェリア
    • エジプト
    • その他

第10章 主要ベンダー分析：神経血管塞栓装置業界

  • 競合ダッシュボード
  • 企業プロファイル
    • Medtronic plc
    • Stryker Corporation
    • Johnson & Johnson Inc.
    • B. Braun Melsungen AG.
    • Integra LifeSciences Corporation
    • Lepu Medical Technology (Beijing) Co.
    • Terumo Corporation
    • Acandis GmBH
    • Phenox GmBH
    • Shape Memory Medical Inc.
    • Others

第11章 AnalystViewの全方位的分析

目次
Product Code: ANV4485

REPORT HIGHLIGHT

Neurovascular Embolization Devices Market size was valued at US$ 1,561.6 Million in 2024, expanding at a CAGR of 8.90% from 2025 to 2032.

Neurovascular embolization devices prevent or limit blood flow to unwanted vascular abnormalities. Neurovascular embolisation devices include aneurysm clips, liquid embolic systems, flow diversion stents, embolisation coils, and intravascular flow disruptors. A stroke occurs when the blood supply to the brain is disrupted, resulting in oxygen deprivation, brain damage, and diminished function. The most frequent cause is clots in the arteries that provide blood to the brain. Hemorrhage, which happens when blood seeps into the brain from a ruptured vessel, may even be the reason. Memory, cognitive, and linguistic issues, as well as partial paralysis, are among the long-term effects of a stroke. The increasing rates of brain stroke and aneurysms, the rise in product authorizations, the positive outcomes of research, market developments like mergers and acquisitions, the introduction of new products, and growing awareness are some of the factors that are expected to drive growth in the global market for neurovascular embolization devices over the forecast period. The growing number of cases and research funding are also expected to help the worldwide market's expansion over the course of the projected period.

Neurovascular Embolization Devices Market- Market Dynamics

Increased Brain Stroke and Aneurysm Cases

Throughout the forecast period, the rising number of brain stroke and aneurysm cases is anticipated to propel the expansion of the global neurovascular embolization devices market. The World Stroke Organization, for example, claims that epidemic proportions of stroke have already been reached. Over 12.2 million individuals are likely to have their first stroke this year, and 6.5 million are expected to die as a result, meaning that 1 in 4 adults over 25 will have a stroke at some point in their lives. Worldwide, more than 110 million people have had a stroke at some time in their life. Over 60% of strokes occur in those under 70, and over 16% occur in people under 50, despite the fact that the prevalence of stroke rises sharply with age. Additionally, NHS England estimates that 1 in 12,500 people in England suffer from a burst brain aneurysm annually. In addition, the Brain Aneurysm Foundation estimates that over 6.0 million Americans suffer from brain aneurysms each year, and over 3.0% of persons in the United Kingdom suffer from one. Moreover, the NIH reports that the prevalence of cerebral aneurysms is approximately 3.2% worldwide, with a standard age of 50 and a gender ratio of 1:1 overall. After age 50, this ratio varies significantly, with a growing female predominance that closes at 2:1. This is thought to be because lower levels of circulating estrogen cause the collagen range of the vascular tissue to diminish.

Neurovascular Embolization Devices Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 8.90% over the forecast period (2025-2032)

Based on product segmentation, the embolic coils were predicted to show maximum market share in the year 2024

Based on end use segmentation, hospitals were the leading category in 2024

On the basis of region, North America was the leading revenue generator in 2024

Neurovascular Embolization Devices Market- Segmentation Analysis:

The Global Neurovascular Embolization Devices Market is segmented on the basis of Product, End Use, and Region.

On the basis of product, the market is segregated into Liquid Embolic Agents, Embolic Coils, Aneurysm Clips, Flow Diversion Devices, and Others. In 2024, the market was dominated by the embolic coils category. Complex platinum devices called embolic coils are inserted into blood arteries to cause clots to form. These coils successfully block aneurysms and other vascular anomalies, lowering the possibility of rupture and ensuing bleeding. Because of their adaptability to a variety of anatomical complications, they are very popular. The development of bioactive and detachable coils has improved the field's efficacy and safety as a result of continuous research and development efforts. Furthermore, one of the most important developments in neurovascular treatments is the use of liquid emboli.

Based on end use, the market is divided into Hospitals, Specialty Clinics, and Others. In 2024, the hospitals category held a dominant market share. Hospitals are the main locations for cutting-edge medical treatments like neurovascular embolization because of their sophisticated technology, large infrastructure, and highly qualified medical personnel. With the newest imaging equipment and interventional suites, these facilities frequently have dedicated neuro interventional units that enable accurate diagnosis and customized care. In hospital settings, having qualified neurosurgeons, interventional radiologists, and neurologists guarantees patients with disorders like aneurysms and arteriovenous malformations full, multidisciplinary care.

Neurovascular Embolization Devices Market- Geographical Insights

In 2024, North America held a dominant position in the global market for Neurovascular Embolization Devices. The market for neurovascular embolization devices is substantial in North America, particularly in the United States and Canada. These countries have high rates of neurovascular diseases, sophisticated healthcare systems, and growing medical expenses. The growth of the regional marketplace is significantly impacted by the heightened government initiatives and manufacturer research and development (R&D) spending. Additionally, the introduction of new products by major industry players to diversify their product lines contributes to the growth of the sector. For instance, India Medtronic's fourth-generation flow deflector, the Pipeline Vantage with Shield Technology, which has a CE mark, was created in June 2022 for endovascular treatment of cerebral aneurysms.

However, throughout the projected period, the Asia-Pacific region is anticipated to see the fastest CAGR. The increasing prevalence of neurological problems, technical breakthroughs, and the growing burden of target diseases are some of the causes of this. Key players' presence and growing healthcare costs are two further factors fueling the region's expansion. The market is also expected to grow more rapidly in the forecast period due to the regional expansion of major players and significant unexplored prospects in Asia Pacific. Three of the biggest suppliers to the neurovascular embolization device market in the area are China, India, and Japan.

Neurovascular Embolization Devices Market- Competitive Landscape:

Key companies in the neurovascular embolization devices are Medtronic plc, Stryker Corporation, Johnson & Johnson Inc., B. Braun Melsungen AG., Integra LifeSciences Corporation, and others. The primary producers of neurovascular embolization devices are concentrating on mergers and acquisitions in order to diversify their product lines. In hospitals and other institutions, businesses are holding conferences and training sessions to inform surgeons and practitioners about the new neurovascular embolization devices. Furthermore, growth initiatives, including new product releases, regulatory approvals, expansions, partnerships, acquisitions, and collaborations, are the main emphasis of the major businesses. For instance, MicroVention, Inc., a neurovascular company under Terumo Corporation, stated in July 2023 that its intravascular device, WEB, has released 5-year monitoring data. In order to make the Aneurysm Embolization Technology more adaptable to aneurysms of different sizes and types, they also included two new sizes (SL 7x2 and SL 6x2). The product is on display at Booth 615 at SNIS 2023 in San Diego. Throughout the projection period, the demand for neurovascular embolization devices will rise as a result of these developments.

Recent Development

February 2023: The first patient treated in Germany as part of the EMBO-Post Market Surveillance Registry, the company's upcoming multicenter registry investigation of its IMPEDE and IMPEDE-FX Embolization Plugs when used for peripheral vascular embolization, was reported by Shape Memory Medical Inc., a manufacturer of shape memory polymers for the peripheral and neurovascular markets.

July 2022: While attending the 19th Annual Conference of the Society of Neurointerventional Surgery (SNIS) in Toronto, Rapid Medical, a company that designs innovative neurovascular devices, received FDA 510(k) permission for TIGERTRIEVER 13 for major artery occlusions.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL NEUROVASCULAR EMBOLIZATION DEVICES MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Medtronic plc
  • Stryker Corporation
  • Johnson & Johnson Inc.
  • B. Braun Melsungen AG.
  • Integra LifeSciences Corporation
  • Lepu Medical Technology (Beijing) Co.
  • Terumo Corporation
  • Acandis GmBH
  • Phenox GmBH
  • Shape Memory Medical Inc.
  • Others

GLOBAL NEUROVASCULAR EMBOLIZATION DEVICES MARKET, BY PRODUCT- MARKET ANALYSIS, 2019 - 2032

  • Liquid Embolic Agents
  • Embolic Coils
  • Aneurysm Clips
  • Flow Diversion Devices
  • Others

GLOBAL NEUROVASCULAR EMBOLIZATION DEVICES MARKET, BY END USE- MARKET ANALYSIS, 2019 - 2032

  • Hospitals
  • Specialty Clinics
  • Others

GLOBAL NEUROVASCULAR EMBOLIZATION DEVICES MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
  • Sweden
  • Russia
  • Poland
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Neurovascular Embolization Devices Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Neurovascular Embolization Devices Market Snippet by Product
    • 2.1.2. Neurovascular Embolization Devices Market Snippet by End Use
    • 2.1.3. Neurovascular Embolization Devices Market Snippet by Country
    • 2.1.4. Neurovascular Embolization Devices Market Snippet by Region
  • 2.2. Competitive Insights

3. Neurovascular Embolization Devices Key Market Trends

  • 3.1. Neurovascular Embolization Devices Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Neurovascular Embolization Devices Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Neurovascular Embolization Devices Market Opportunities
  • 3.4. Neurovascular Embolization Devices Market Future Trends

4. Neurovascular Embolization Devices Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Neurovascular Embolization Devices Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Neurovascular Embolization Devices Market Landscape

  • 6.1. Neurovascular Embolization Devices Market Share Analysis, 2024
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Neurovascular Embolization Devices Market - By Product

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Product, 2024 & 2032 (%)
    • 7.1.2. Liquid Embolic Agents
    • 7.1.3. Embolic Coils
    • 7.1.4. Aneurysm Clips
    • 7.1.5. Flow Diversion Devices
    • 7.1.6. Others

8. Neurovascular Embolization Devices Market - By End Use

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By End Use, 2024 & 2032 (%)
    • 8.1.2. Hospitals
    • 8.1.3. Specialty Clinics
    • 8.1.4. Others

9. Neurovascular Embolization Devices Market- By Geography

  • 9.1. Introduction
    • 9.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
  • 9.2. North America
    • 9.2.1. Overview
    • 9.2.2. Neurovascular Embolization Devices Key Manufacturers in North America
    • 9.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 9.2.4. North America Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 9.2.5. North America Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 9.2.6. U.S.
      • 9.2.6.1. Overview
      • 9.2.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.2.6.3. U.S. Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 9.2.6.4. U.S. Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 9.2.7. Canada
      • 9.2.7.1. Overview
      • 9.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.2.7.3. Canada Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 9.2.7.4. Canada Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
  • 9.3. Europe
    • 9.3.1. Overview
    • 9.3.2. Neurovascular Embolization Devices Key Manufacturers in Europe
    • 9.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 9.3.4. Europe Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 9.3.5. Europe Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 9.3.6. Germany
      • 9.3.6.1. Overview
      • 9.3.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.6.3. Germany Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 9.3.6.4. Germany Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 9.3.7. France
      • 9.3.7.1. Overview
      • 9.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.7.3. France Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 9.3.7.4. France Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 9.3.8. Italy
      • 9.3.8.1. Overview
      • 9.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.8.3. Italy Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 9.3.8.4. Italy Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 9.3.9. Spain
      • 9.3.9.1. Overview
      • 9.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.9.3. France Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 9.3.9.4. France Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 9.3.10. United Kingdom
      • 9.3.10.1. Overview
      • 9.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.10.3. United Kingdom Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 9.3.10.4. United Kingdom Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 9.3.11. Russia
      • 9.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.11.2. Russia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 9.3.11.3. Russia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 9.3.12. Netherlands
      • 9.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.12.2. Netherlands Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 9.3.12.3. Netherlands Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 9.3.13. Sweden
      • 9.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.13.2. Sweden Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 9.3.13.3. Sweden Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 9.3.14. Poland
      • 9.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.14.2. Poland Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 9.3.14.3. Poland Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 9.3.15. Rest of Europe
      • 9.3.15.1. Overview
      • 9.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.15.3. Rest of the Europe Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 9.3.15.4. Rest of the Europe Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
  • 9.4. Asia Pacific (APAC)
    • 9.4.1. Overview
    • 9.4.2. Neurovascular Embolization Devices Key Manufacturers in Asia Pacific
    • 9.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 9.4.4. Asia Pacific Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 9.4.5. Asia Pacific Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 9.4.6. India
      • 9.4.6.1. Overview
      • 9.4.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.6.3. India Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 9.4.6.4. India Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 9.4.7. China
      • 9.4.7.1. Overview
      • 9.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.7.3. China Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 9.4.7.4. China Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 9.4.8. South Korea
      • 9.4.8.1. Overview
      • 9.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.8.3. South Korea Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 9.4.8.4. South Korea Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 9.4.9. Japan
      • 9.4.9.1. Overview
      • 9.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.9.3. Japan Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 9.4.9.4. Japan Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 9.4.10. Australia
      • 9.4.10.1. Overview
      • 9.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.10.3. Australia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 9.4.10.4. Australia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 9.4.11. Thailand
      • 9.4.11.1. Overview
      • 9.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.11.3. Thailand Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 9.4.11.4. Thailand Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 9.4.12. Indonesia
      • 9.4.12.1. Overview
      • 9.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.12.3. Indonesia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 9.4.12.4. Indonesia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 9.4.13. Philippines
      • 9.4.13.1. Overview
      • 9.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.13.3. Philippines Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 9.4.13.4. Philippines Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 9.4.14. Rest of APAC
      • 9.4.14.1. Overview
      • 9.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.14.3. Rest of APAC Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 9.4.14.4. Rest of APAC Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
  • 9.5. Latin America
    • 9.5.1. Overview
    • 9.5.2. Neurovascular Embolization Devices Key Manufacturers in Latin America
    • 9.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 9.5.4. Latin America Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 9.5.5. Latin America Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 9.5.6. Brazil
      • 9.5.6.1. Overview
      • 9.5.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.5.6.3. Brazil Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 9.5.6.4. Brazil Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 9.5.7. Mexico
      • 9.5.7.1. Overview
      • 9.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.5.7.3. Mexico Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 9.5.7.4. Mexico Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 9.5.8. Argentina
      • 9.5.8.1. Overview
      • 9.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.5.8.3. Argentina Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 9.5.8.4. Argentina Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 9.5.9. Colombia
      • 9.5.9.1. Overview
      • 9.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.5.9.3. Colombia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 9.5.9.4. Colombia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 9.5.10. Rest of LATAM
      • 9.5.10.1. Overview
      • 9.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.5.10.3. Rest of LATAM Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 9.5.10.4. Rest of LATAM Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
  • 9.6. Middle East and Africa
    • 9.6.1. Overview
    • 9.6.2. Neurovascular Embolization Devices Key Manufacturers in Middle East and Africa
    • 9.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 9.6.4. Middle East and Africa Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 9.6.5. Middle East and Africa Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 9.6.6. Saudi Arabia
      • 9.6.6.1. Overview
      • 9.6.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.6.3. Saudi Arabia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 9.6.6.4. Saudi Arabia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 9.6.7. United Arab Emirates
      • 9.6.7.1. Overview
      • 9.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.7.3. United Arab Emirates Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 9.6.7.4. United Arab Emirates Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 9.6.8. Israel
      • 9.6.8.1. Overview
      • 9.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.8.3. Israel Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 9.6.8.4. Israel Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 9.6.9. Turkey
      • 9.6.9.1. Overview
      • 9.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.9.3. Turkey Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 9.6.9.4. Turkey Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 9.6.10. Algeria
      • 9.6.10.1. Overview
      • 9.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.10.3. Algeria Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 9.6.10.4. Algeria Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 9.6.11. Egypt
      • 9.6.11.1. Overview
      • 9.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.11.3. Egypt Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 9.6.11.4. Egypt Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 9.6.12. Rest of MEA
      • 9.6.12.1. Overview
      • 9.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.12.3. Rest of MEA Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 9.6.12.4. Rest of MEA Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)

10. Key Vendor Analysis- Neurovascular Embolization Devices Industry

  • 10.1. Competitive Dashboard
  • 10.2. Company Profiles
    • 10.2.1. Medtronic plc
    • 10.2.2. Stryker Corporation
    • 10.2.3. Johnson & Johnson Inc.
    • 10.2.4. B. Braun Melsungen AG.
    • 10.2.5. Integra LifeSciences Corporation
    • 10.2.6. Lepu Medical Technology (Beijing) Co.
    • 10.2.7. Terumo Corporation
    • 10.2.8. Acandis GmBH
    • 10.2.9. Phenox GmBH
    • 10.2.10. Shape Memory Medical Inc.
    • 10.2.11. Others

11. 360 Degree Analyst View

12. Appendix

  • 12.1. Research Methodology
  • 12.2. References
  • 12.3. Abbreviations
  • 12.4. Disclaimer
  • 12.5. Contact Us